Beijing Strong Biotechnologies has recently obtained two Medical Device Registration Certificates from the Beijing Medical Products Administration. The Antithrombin III Assay Kit (Chromogenic Substrate Method) and the Osteocalcin Assay Kit (Magnetic Particle Chemiluminescence Immunoassay) are both Class II devices, valid until July 5, 2031. They are used for the in vitro quantitative determination of antithrombin III activity in human plasma and osteocalcin levels in human serum or plasma, respectively. The company stated that obtaining these certificates enriches its product lines in the coagulation and chemiluminescence segments, helping to enhance core competitiveness and market expansion capabilities. However, actual sales will depend on future market promotion results, and the impact on performance cannot yet be predicted.
Beijing Strong Biotechnologies IncObtained two new medical device registration certificates, expanding product lines in coagulation and chemiluminescence segments.